Project Details
Description
An Open-Label, Safety Study for Previously Treated Ataluren (PTC124) Patients with Nonsense Mutation Dystrophinopathy
Status | Active |
---|---|
Effective start/end date | 11/1/10 → 2/28/25 |
Funding
- PTC THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.